(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Profit adjustment | ||||||||||
Impairment and provisions: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Asset sale loss (gain): | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Depreciation and amortization: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Operating profit before the change of operating capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Change of operating capital | ||||||||||
Cash from business operations | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Net cash from operations | -33.65%197.77M | -3.06%3.34B | -7.65%2.05B | -5.90%1.27B | 92.67%298.09M | -9.90%3.44B | -3.01%2.22B | 36.19%1.35B | 26.72%154.72M | -4.00%3.82B |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | 14,317.08%720.85K | 43.04%14.92M | -4.65%8.67M | 8.85%8.11M | -99.65%5K | 5.74%10.43M | 141.25%9.09M | 1,107.88%7.45M | 154.92%1.44M | 658.18%9.87M |
Purchase of fixed assets | 73.69%-29.38M | 80.45%-667.57M | 91.89%-234.4M | 93.19%-154.76M | -90.75%-111.67M | 10.71%-3.41B | -586.07%-2.89B | -1,767.84%-2.27B | -9.74%-58.54M | -714.25%-3.82B |
Recovery of cash from investments | ---- | 308.54%90.9M | ---- | ---- | ---- | -99.49%22.25M | -99.61%15.4M | -99.95%1.98M | ---- | -27.56%4.4B |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 36.36%-3.5B |
Other items in the investment business | -403.42%-383.38K | -28.59%212.61M | 13.85%157.76M | 74.80%108.75M | -95.35%126.35K | 31.47%297.73M | 36.19%138.57M | -14.90%62.21M | 104.85%2.72M | -64.45%226.46M |
Net cash from investment operations | 73.96%-29.04M | 88.68%-349.15M | 97.51%-67.97M | 98.28%-37.9M | -105.10%-111.54M | -14.80%-3.08B | -566.17%-2.73B | -357.93%-2.2B | 97.00%-54.38M | -460.84%-2.69B |
Net cash before financing | -9.55%168.73M | 730.24%2.99B | 489.95%1.98B | 245.47%1.23B | 85.92%186.54M | -68.30%360.14M | -117.69%-508.4M | -145.97%-848.72M | 105.94%100.33M | -75.96%1.14B |
Cash flow from financing activities | ||||||||||
New borrowing | --998M | -50.90%2.5B | -43.53%2.5B | -65.02%1.5B | ---- | 445.71%5.09B | 695.32%4.42B | 838.60%4.28B | ---- | -35.81%932M |
Refund | -275.00%-150M | -84.77%-4.21B | -179.08%-4.21B | -24.99%-1.71B | ---40M | 36.47%-2.28B | 52.91%-1.51B | 56.00%-1.36B | ---- | 14.06%-3.58B |
Dividends paid - financing | -48.08%-11.7M | 15.17%-845.82M | 20.37%-702.82M | -259.92%-256.44M | 23.39%-7.9M | 36.33%-997.11M | 22.12%-882.64M | 76.76%-71.25M | 79.65%-10.31M | -2.13%-1.57B |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.08B |
Other items of the financing business | 36.48%-52.47M | 68.87%-474.71M | 77.39%-302.21M | 82.66%-174.57M | -190.64%-82.59M | 11.79%-1.52B | -206.29%-1.34B | -267.80%-1.01B | 74.63%-28.42M | -321.31%-1.73B |
Net cash from financing operations | 700.68%783.84M | -1,150.60%-3.03B | -489.73%-2.71B | -134.77%-639.01M | -236.95%-130.49M | 107.46%288.27M | 116.52%696.13M | 157.00%1.84B | 88.11%-38.73M | 17.10%-3.86B |
Effect of rate | 302.02%2.99M | -176.81%-7.98M | -5.23%6.83M | -3.82%3.89M | -411.48%-1.48M | 316.70%10.4M | 59.65%7.21M | 849.07%4.04M | -113.64%-289.38K | 4.09%-4.8M |
Net Cash | 1,650.96%955.56M | -107.06%-46.49M | -471.22%-723.68M | -39.64%599.48M | -11.00%54.57M | 124.12%658.81M | 114.61%194.95M | 172.10%993.23M | 103.04%61.32M | -4,508.64%-2.73B |
Begining period cash | -0.89%5.2B | 14.36%5.25B | 13.80%5.05B | 13.80%5.05B | 18.33%5.25B | -35.98%4.59B | -38.12%4.43B | -38.12%4.43B | -38.12%4.43B | 0.87%7.17B |
Cash at the end | 16.12%6.16B | -0.89%5.2B | -6.63%4.32B | 4.02%5.64B | 17.93%5.3B | 18.33%5.25B | -20.61%4.63B | -6.23%5.43B | -12.74%4.49B | -38.12%4.43B |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data